Kevin S. Harris
Corporate Officer/Principal bij American Society for Virology
Profiel
Kevin Harris is Virology Director of Koronis Pharmaceuticals, Inc. and a Member of the American Society for Virology.
Prior to joining Koronis Pharmaceuticals, he was a Senior Molecular Biologist at Abbott Laboratories.
Dr. Harris received a PhD from SUNY Stony Brook in 1994.
Actieve functies van Kevin S. Harris
| Bedrijven | Functie | Begin |
|---|---|---|
| American Society for Virology | Corporate Officer/Principal | 17-04-2009 |
Eerdere bekende functies van Kevin S. Harris
| Bedrijven | Functie | Einde |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Koronis Pharmaceuticals, Inc.
 Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Opleiding van Kevin S. Harris
| Stony Brook University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Koronis Pharmaceuticals, Inc.
Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Health Technology |
| American Society for Virology |
